Targeted therapy for colorectal cancer: mapping the way
- 31 July 2005
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 11 (7) , 327-335
- https://doi.org/10.1016/j.molmed.2005.05.002
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Combination of Antiangiogenic Therapy With Other Anticancer Therapies: Results, Challenges, and Open QuestionsJournal of Clinical Oncology, 2005
- Systemic Therapy for Colorectal CancerNew England Journal of Medicine, 2005
- Colorectal cancerThe Lancet, 2005
- Erlotinib hydrochlorideNature Reviews Drug Discovery, 2005
- Targeted Therapies for Cancer 2004American Journal of Clinical Pathology, 2004
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- Antiangiogenic cancer therapySeminars in Cancer Biology, 2004
- Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2003
- Monoclonal antibodies combined to chemotherapy for the treatment of patients with lymphomaBlood Reviews, 2002
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2New England Journal of Medicine, 2001